Back to Authors

Benga, Kebede

A5092681391 | I1330342723

Mayo Clinic

Citations 5

P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

HemaSphere | August 25, 2023 | Volume: 7 | Issue: S3 | Pages: e81209ff

10.1097/01.hs9.0000969892.81209.ff

PB1888: TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

HemaSphere | August 23, 2023 | Volume: 7 | Issue: S3 | Pages: e12654b3

10.1097/01.hs9.0000974376.12654.b3

P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e8757030

10.1097/01.hs9.0000969792.87570.30

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e84724f8

10.1097/01.hs9.0000969224.84724.f8

P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

HemaSphere | August 10, 2023 | Volume: 7 | Issue: S3 | Pages: e65989e7

10.1097/01.hs9.0000969840.65989.e7